Inner Mongolia Furui Med Sci (300049) — Net Asset Quality Index
Inner Mongolia Furui Med Sci (300049) has a Net Asset Quality Index of 72.5% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.42 Billion minus total liabilities of CN¥940.06 Million yields net assets of CN¥2.48 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 300049 financial resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Inner Mongolia Furui Med Sci Net Asset Quality Index Over Time (2006–2025)
This chart shows how Inner Mongolia Furui Med Sci's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of March 2026, the index stands at 72.5%, representing net assets of CN¥2.48 Billion against total assets of CN¥3.42 Billion CNY. See 300049 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Inner Mongolia Furui Med Sci (2006–2025)
The table below presents the year-by-year Net Asset Quality Index for Inner Mongolia Furui Med Sci from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 300049 market cap.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 81.0% | CN¥2.79 Billion | CN¥3.44 Billion | CN¥652.21 Million | ▲ +11.5 pp |
| 2024 | 69.6% | CN¥2.13 Billion | CN¥3.06 Billion | CN¥930.99 Million | ▼ -0.2 pp |
| 2023 | 69.8% | CN¥1.85 Billion | CN¥2.65 Billion | CN¥800.09 Million | ▼ -2.6 pp |
| 2022 | 72.4% | CN¥1.83 Billion | CN¥2.52 Billion | CN¥697.25 Million | ▲ +0.8 pp |
| 2021 | 71.5% | CN¥1.81 Billion | CN¥2.52 Billion | CN¥718.97 Million | ▲ +1.0 pp |
| 2020 | 70.5% | CN¥1.62 Billion | CN¥2.29 Billion | CN¥675.02 Million | ▲ +1.6 pp |
| 2019 | 69.0% | CN¥1.55 Billion | CN¥2.25 Billion | CN¥698.66 Million | ▼ -1.9 pp |
| 2018 | 70.9% | CN¥1.51 Billion | CN¥2.14 Billion | CN¥622.47 Million | ▼ -5.5 pp |
| 2017 | 76.3% | CN¥1.92 Billion | CN¥2.51 Billion | CN¥594.42 Million | ▲ +0.5 pp |
| 2016 | 75.9% | CN¥1.83 Billion | CN¥2.41 Billion | CN¥581.15 Million | ▼ -5.0 pp |
| 2015 | 80.9% | CN¥1.65 Billion | CN¥2.04 Billion | CN¥390.37 Million | ▲ +12.1 pp |
| 2014 | 68.7% | CN¥915.10 Million | CN¥1.33 Billion | CN¥416.10 Million | ▲ +3.2 pp |
| 2013 | 65.6% | CN¥748.53 Million | CN¥1.14 Billion | CN¥393.25 Million | ▼ -13.5 pp |
| 2012 | 79.1% | CN¥733.64 Million | CN¥927.58 Million | CN¥193.94 Million | ▼ -1.4 pp |
| 2011 | 80.5% | CN¥703.08 Million | CN¥873.44 Million | CN¥170.37 Million | ▼ -5.9 pp |
| 2010 | 86.4% | CN¥687.42 Million | CN¥795.66 Million | CN¥108.24 Million | ▲ +23.7 pp |
| 2009 | 62.7% | CN¥157.46 Million | CN¥250.96 Million | CN¥93.51 Million | ▲ +0.2 pp |
| 2008 | 62.5% | CN¥139.52 Million | CN¥223.10 Million | CN¥83.58 Million | ▼ -1.0 pp |
| 2007 | 63.6% | CN¥127.76 Million | CN¥200.93 Million | CN¥73.17 Million | ▼ -2.7 pp |
| 2006 | 66.3% | CN¥124.50 Million | CN¥187.80 Million | CN¥63.29 Million | — |